Back to programme
Thu 23 Oct 25 14:00-15:40
SCS
Late Breakers: novel and outstanding discoveries SCS15 PLE
Auditorium 1 - Plenary Hall
Chairs
Sylvie VAN DER WERF
ESWI Associate Member, Institut Pasteur, France
Read more
Carolien VAN DE SANDT
ESWI Associate Member, Murdoch Children’s Research Institute, Melbourne, Australia
Read more
Ended Now live Upcoming
  1. Opening of the session
    Sylvie VAN DER WERFESWI Associate Member, Institut Pasteur, France
    Carolien VAN DE SANDTESWI Associate Member, Murdoch Children’s Research Institute, Melbourne, Australia
  2. 1. mRNA-1010, an mRNA-Based Influenza Vaccine, is Safe and Efficacious in Adults Aged ≥50 Years, Including Individuals at High Risk for Severe Disease
    Rituparna DASModerna Therapeutics, United States
  3. 2. A real-life study revealed the presence of more than 10% nirsevimab escape mutants in RSV-B breakthrough infections.
    Marie-Anne RAMEIX-WELTIInstitut Pasteur CNR Vir (Bat Jacob, France
  4. 3. Prior immunity with seasonal influenza A(H3N2) virus confers varying levels of protection against clade 2.3.4.4b A(H5N1), A(H7N9), or A(H9N2) virus challenge in a ferret model
    To be confirmed
  5. 4. Adjuvanted inactivated zoonotic influenza A(H5N8) vaccination induces antibody and T-cell responses to emerging HPAI clade 2.3.4.4b A(H5N1) viruses in healthcare workers
    To be confirmed
  6. 5. Translational efficacy of CD388, a novel Drug Fc-Conjugate (DFC), in mouse influenza infection models: application to prevention efficacy in the recently completed Ph2b NAVIGATE clinical study
    Voon ONGCidara, United States
  7. 6. Effectiveness of HD-IIV against laboratory-confirmed influenza infection and patient-centered outcomes in the community: a DANFLU-2 sub-study
    Filip Soeskov DAVIDOVSKIHerlev and Gentofte Hospital, Denmark
  8. 7. Induction of strong innate immune response in human alveolar epithelium is correlated with pathogenicity of avian influenza viruses
    Meaghan FLAGGNIAID, NIH, United States
  9. Closing remarks
    Sylvie VAN DER WERFESWI Associate Member, Institut Pasteur, France
    Carolien VAN DE SANDTESWI Associate Member, Murdoch Children’s Research Institute, Melbourne, Australia